Table 5.
The prognosis of pancreatic cancer relevant genes and clinical factors
| Features | Coef in coxPH | Hazard ratio | P-values |
|---|---|---|---|
| Gene features | |||
| FABP6 | −0.0728 | 0.6701 | 4.55E-05 |
| REG4 | 0.0570 | 1.3042 | 0.000523 |
| MAL | 0.0175 | 2.2394 | 0.001079 |
| KIF19 | 0.0419 | 1.787 | 0.001551 |
| CCK | −0.0377 | 0.6613 | 0.002994 |
| FER1L6 | −0.0557 | 0.7896 | 0.003862 |
| SFTPA2 | 0.0597 | 1.8497 | 0.004024 |
| GSTM1 | 0.0331 | 1.1257 | 0.004456 |
| MUC17 | −0.0076 | 0.8364 | 0.006349 |
| UPK1B | 0.0868 | 1.2045 | 0.007586 |
| HEPACAM2 | −0.0877 | 0.766 | 0.016981 |
| TNNT2 | 0.0155 | 1.5525 | 0.017516 |
| NLRP2 | −0.0920 | 0.8446 | 0.017973 |
| G6PC2 | −0.0075 | 0.6703 | 0.033274 |
| KLK8 | 0.0336 | 1.2119 | 0.03853 |
| FABP6 | −0.0728 | 0.6701 | 4.55E-05 |
| Clinic features | |||
| Pathologic_N | 0.6794 | 1.805 | 0.04824 |
| New tumor | 0.4940 | 1.921 | 0.01218 |
| Targeted molecular therapy | −0.9077 | 0.362 | 0.000356 |